Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release Capsule, Extended Release
Product Images NDC 42858-215

7 FDA label images from Rhodes Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release (NDC 42858-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 01)

Figure 1 (Amphetamine 01)
A line graph showing mean plasma concentrations of dextroamphetamine and levoamphetamine over 24 hours after dosing. The x-axis represents time in hours, and the y-axis represents mean plasma concentrations (ng/mL). Two treatments are compared: Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules 20 mg once daily, and Adderall 10 mg twice daily. Separate lines show plasma levels for dextroamphetamine and levoamphetamine for each treatment.*
FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

Principal Display Panel (5 mg Capsule Bottle Label)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules, 5 mg strength. The label shows the product name, dosage form, strength, and that it contains 100 capsules. It also notes the labeler as Rhodes Pharmaceuticals LLC and includes usage instructions to dispense the accompanying medication guide. The label lists the active ingredients individually and includes storage instructions and barcodes.*
FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Principal Display Panel (10 mg Capsule Bottle Label)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules 10 mg. Packaged by Rhodes Pharmaceuticals LLC, the label shows a quantity of 100 capsules. It includes dosage strength, storage instructions, and a pharmacist dispensing warning for a medication guide. The label details active ingredients per capsule and lists the product as prescription only.*
FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

Principal Display Panel (15 mg Capsule Bottle Label)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules 15 mg, marketed by Rhodes Pharmaceuticals. The label shows a package of 100 capsules, with dosage and pharmacist dispensing instructions. The label includes storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Principal Display Panel (20 mg Capsule Bottle Label)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules, 20 mg strength. The label shows a white background with text in black and red, listing the active ingredients as mixed salts of a single-entity amphetamine product. It indicates the product is prescription-only and includes storage instructions, a barcode, and that it contains 100 capsules. Marketed by Rhodes Pharmaceuticals LLC.*
FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Principal Display Panel (25 mg Capsule Bottle Label)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules, 25 mg strength. The label notes the product is marketed by Rhodes Pharmaceuticals L.P., Coventry, RI. It includes storage instructions, a directive for pharmacists to dispense the medication guide, and a list of the active salts and their quantities per capsule. The package contains 100 capsules.*
FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Principal Display Panel (30 mg Capsule Bottle Label)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules, 30 mg strength, marketed by Rhodes Pharmaceuticals LLC. The label states the product is for prescription use only, contains 100 capsules, and includes directions for pharmacists to dispense a medication guide to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.